AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,369,089 | $39,042,585 | 17.18% |
| Knoll Capital Management, LLC | 500,000 | $8,240,000 | 9.99% |
| GENDELL JEFFREY L | 5,396,060 | $88,927,069 | 6.90% |
| Tri Locum Partners LP | 1,039,474 | $17,130,532 | 6.37% |
| Vivo Capital, LLC | 3,829,577 | $63,111,429 | 4.36% |
| COWEN AND COMPANY, LLC | 2,664,076 | $43,903,972 | 3.64% |
| Samsara BioCapital, LLC | 967,527 | $15,944,845 | 2.80% |
| RTW INVESTMENTS, LP | 6,810,641 | $112,239,364 | 2.14% |
| Knott David M Jr | 240,629 | $3,966 | 1.58% |
| Velan Capital Investment Management LP | 100,000 | $1,648,000 | 1.53% |
| MPM BioImpact LLC | 384,990 | $6,344,635 | 1.28% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 93,975 | $1,548,708 | 0.80% |
| SCHULHOFF & CO INC | 96,000 | $1,582,080 | 0.74% |
| ADVISORY RESEARCH INC | 270,077 | $4,450,870 | 0.57% |
| Soleus Capital Management, L.P. | 307,000 | $5,059,360 | 0.56% |
| Edge Wealth Management LLC | 150,000 | $2,472,000 | 0.54% |
| BRANDES INVESTMENT PARTNERS, LP | 1,289,195 | $21,245,933 | 0.43% |
| Portolan Capital Management | 289,906 | $4,777,651 | 0.42% |
| Polar Capital Holdings Plc | 4,534,921 | $74,735,498 | 0.38% |
| Woodline Partners LP | 1,879,343 | $30,971,573 | 0.37% |
External links
This page lists AVADEL PHARMACEUTICALS PLC's shareholders in Q2 2023. To view AVADEL PHARMACEUTICALS PLC's shareholder history, click here.